Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates

Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates

The active ingredient in a pharmaceutical drug is called an heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates. An example of an API is the acetaminophen contained in a pain relief tablet. The active ingredient in a biological drug is called a bulk process intermediate (BPI).
Send Inquiry
Description

What is Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates

 

 

The active ingredient in a pharmaceutical drug is called an heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates. An example of an API is the acetaminophen contained in a pain relief tablet. The active ingredient in a biological drug is called a bulk process intermediate (BPI).

 

Why Choose us

Excellent Team
The company has hired senior experts and PhDs in the field of biochemical synthesis in China to lead the guidance, and has a leading core team consisting of senior engineer Zeng Fanrong with a master's degree and multiple undergraduate research and development personnel.

 

Quality Services
Team members possess multilingual skills and are able to adapt to the diverse needs of the international market, establishing stable cooperative relationships with global clients.

 

Quality Assurance
We produce merchandise of the highest possible standard. Possessing the technology and skills to reach the requirements of our clients, we ensure that the merchandise produced reflects our commitment to providing our clients with a fast, reliable and cost-effective service without compromising on quality.

 

Related Products
 
product-378-378

Folic Acid CAS#59-30-3

Huarong is the supplier of Folic acid CAS#59-30-3 in China,we supply the USP/BP and feed grade(80% and 96% ).

D-生物素/维生素 H

D-Biotin/Vitamin H

A valeric acid substituent is attached to one of the carbon atoms of the tetrahydrothiophene ring.

阿齐沙坦 CAS#147403-03-0

Azilsartan CAS#147403-03-0

Azilsartan is an antagonist of the angiotensin II type 1 receptor (AT1; IC50 = 0.42 μM) and the active metabolite of azilsartan medoxomil .

布洛芬 API(CAS#15687-27-1)

Ibuprofen API (CAS#15687-27-1)

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID). It works by inhibiting the production of prostaglandins, which are chemicals in the body that cause inflammation, pain, and fever.

单硝酸异山梨酯 API (CAS#16106-20-0)

Isosorbide Mononitrate API (CAS#16106-20-0)

Isosorbide mononitrate is a vasodilator. It works by relaxing the smooth muscles in blood vessels, leading to dilation of arteries and veins.

泛酸钠 (CAS#867-81-2)

Sodium Pantothenate (CAS#867-81-2)

Sodium pantothenate is a form of vitamin B5. It plays a crucial role in various metabolic processes in the body.

伏立康唑 CAS#137234-62-9

Voriconazole CAS#137234-62-9

Voriconazole is an antifungal agent. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes.

兰索拉唑 CAS#103577-45-3

Lansoprazole CAS#103577-45-3

Lansoprazole is the second proton pump inhibitor approved as an antiulcer agent for the short term treatment of duodenal ulcer and gastroesophageal reflux disease.

雷贝拉唑钠 CAS#117976-90-6

Rebeprazole Sodium CAS#117976-90-6

Rabeprazole is a proton pump inhibitor that selectively and irreversibly inhibits the gastric H+/K+ ATPase (IC50 = 72 nM).

 

Types of Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates

 

Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are broadly categorised into two types – synthetic and natural. Synthetic APIs are further classified into innovative and generic synthetic APIs, based on the type of synthesis used.

 

Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates, also known as small molecules, constitute a large part of the pharmaceutical market, with many small molecule drugs commercially available in the market.

 

Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are used in making biologics, which are increasingly becoming the top-selling drugs in the market. Despite the growing demand, biologics are currently significantly fewer in number compared to small molecule drugs.

 

Based on the solubility, Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are categorised into insoluble and soluble drugs.

 

Application of Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates
product-1-1
product-1-1
product-1-1
product-1-1

A Vial Of Heparin Sodium Salt Cas 9041-08-1 Sodium For Injection

Heparin sodium salt CAS 9041-08-1 acts as an anticoagulant, preventing the formation of clots and extension of existing clots within the blood. Heparin sodium salt CAS 9041-08-1 itself does not break down clots that have already formed, instead it prevents clot formation by inhibiting thrombin and other procoagulant serine proteases. Heparin sodium salt CAS 9041-08-1 is generally used for anticoagulation for the following conditions:

  • Acute coronary syndrome, e.g., NSTEMI
  • Atrial fibrillation
  • Deep-vein thrombosis and pulmonary embolism (both prevention and treatment)
  • Other thrombotic states and conditions
  • Cardiopulmonary bypass for heart surgery
  • ECMO circuit for extracorporeal life support
  • Hemofiltration


Indwelling Central Or Peripheral Venous Catheters
Heparin sodium salt CAS 9041-08-1 and its low-molecular-weight derivatives (e.g., enoxaparin, dalteparin, tinzaparin) are effective in preventing deep vein thromboses and pulmonary emboli in people at risk,but no evidence indicates any one is more effective than the other in preventing mortality.

In angiography, 2 to 5 units/mL of unfractionated heparin sodium salt CAS 9041-08-1 saline flush is used as a locking solution to prevent the clotting of blood in guidewires, sheaths, and catheters, thus preventing thrombus from dislodging from these devices into the circulatory system .

Unfractionated heparin sodium salt CAS 9041-08-1 is used in hemodialysis. Comparing to low-molecular-weight heparin sodium salt CAS 9041-08-1, unfractionated heparin sodium salt CAS 9041-08-1 does not have prolonged anticoagulation action after dialysis, and low cost. However, the short duration of action for heparin sodium salt CAS 9041-08-1 would require it to maintain continuous infusion to maintain its action. Meanwhile, unfractionated heparin sodium salt CAS 9041-08-1 has higher risk of heparin-induced thrombocytopenia.

 

How to use Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates
 

Read the Patient Information Leaflet if available from your pharmacist before you start using heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates and each time you get a refill. If you have any questions, ask your doctor or pharmacist.

 

This medication is given by injection into a vein or under the skin as directed by your doctor. Do not inject this medication into a muscle. The dosage and how often you use it are based on your medical condition, weight, and response to treatment.

 

Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates comes in many strengths. Serious (sometimes fatal) injuries have occurred when the wrong strength was used. Check that you are using the correct strength and dose before injecting this medication.

 

If you are giving this medication to yourself at home, learn all preparation and usage instructions from your health care professional. Before using, check this product for particles or discoloration. If either is present, do not use the liquid. Learn how to store and discard medical supplies safely.

 

If you are injecting Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates into a vein, flush the catheter/line with normal saline before and after infusing drugs that interact with heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates such as doxorubicin, droperidol, ciprofloxacin, and mitoxantrone.

 

If you are injecting heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates under the skin, clean the skin you are going to inject into (the injection site) with rubbing alcohol. Change the injection site each time to lessen injury under the skin.

 

Use this medication regularly to get the most benefit from it. To help you remember, use it at the same times each day.

 

Key Differences between APIs and Heparin Sodium Salt CAS 9041-08-1 Active Pharmaceutical Ingredients And Intermediates

 

 

The main differences between API and heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates can be summarized as follows:

 

Definition: APIs are the active substances in pharmaceutical products, directly interacting with the body for therapeutic effects.


Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are synthesized compounds used during API production at different stages.

 

Function: APIs have direct therapeutic function, treating medical conditions. In contrast, heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates facilitate API synthesis as building blocks or precursors without direct therapeutic function.

 

Use and Application: APIs are final products used in pharmaceutical formulations for patient use, providing therapeutic effects.

 

Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are used solely in API manufacturing and not administered to patients directly.

 

Regulatory Approval: APIs undergo rigorous testing and regulatory approval for quality, safety, and efficacy in pharmaceutical products. In contrast, heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates have fewer regulatory requirements as they are used within the manufacturing process.

 

Chemical Structure and Complexity: APIs are fully formed compounds that produce therapeutic effects, while heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates are partially formed compounds undergoing further modifications.

 

 
Company Introduction

 

Huarong (Guangdong) Pharmaceutical Co., Ltd. is a pharmaceutical intermediate manufacturing and production company, based on the synthesis of DPP-4 inhibitor intermediates. It comprehensively constructs a production line for active ingredients of bisamide insecticides, as well as a multifunctional production line for chiral synthesis and enzymatic synthesis of compound intermediates. Build an advanced and green comprehensive production base for pharmaceutical and pesticide intermediates.

The company was established on November 8, 2023, with a type of other limited liability company and registered in Nanxiong City, Shaoguan City. The company's project plan covers an area of 53406.97 square meters. The main building includes 5 Class A multifunctional workshops, 1 Class C workshop, 1 comprehensive building, 1 quality inspection and research and development building, as well as supporting power and environmental protection facilities. The construction of the project covers an area of 19042 square meters, with a building area of 50137 square meters and a plot ratio of 0.94.

product-1-1

 

 
Asked Questions
 

Q: What is the difference between heparin and Heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates?

A: Heparin is strongly acidic because of its content of covalently linked sulfate and carboxylic acid groups. In heparin sodium salt CAS 9041-08-1 salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates, the acidic protons of the sulfate units are partially replaced by sodium ions.

Q: What is the ingredient in heparin sodium salt CAS 9041-08-1?

A: Each mL of the 10,000 USP units per mL preparations contains: heparin sodium salt CAS 9041-08-1 10,000 USP units; 9.45 mg benzyl alcohol added as preservative. The preservative-free product contains (per mL): 1,000 USP units of heparin sodium salt CAS 9041-08-1 and 9 mg sodium chloride.

Q: What does heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates do to the body?

A: It is used to decrease the clotting ability of the blood and help prevent harmful clots from forming in blood vessels. This medicine is sometimes called a blood thinner, although it does not actually thin the blood.

Q: Is heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates an anti inflammatory?

A: Abstract. Heparin is a glycosaminoglycan well known for its anticoagulant properties. In addition, heparin possesses anti-inflammatory effects. Although the mechanisms responsible for the anticoagulant effects of heparin are well understood, those underlying its anti-inflammatory effects are not.

Q: What does heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates sodium treat?

A: Healthcare providers use heparin to treat or prevent blood clots that can cause you harm. You may receive heparin if you have: Venous thromboembolism (VTE), a blood clot in your vein. Deep vein thrombosis (DVT), a clot in a deep vein in your leg or arm.

Q: What are the benefits of heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates?

A: Heparin sodium salt CAS 9041-08-1 is primarily used to prevent and treat blood clots by inhibiting the production of fibrin (a protein that binds platelets together and forms a clot). Heparin sodium salt CAS 9041-08-1 also reduces the risk of blood clots during surgeries (like heart surgery).

Q: How do you know if heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates is working?

A: Currently, the Activated Partial Thromboplastin Time (aPTT) is the laboratory test most commonly used to monitor UNFRACTIONATED HEPARIN THERAPY. However, some patients receiving heparin sodium salt CAS 9041-08-1 but not demonstrating an adequate aPTT prolongation may require further laboratory evaluation for heparin sodium salt CAS 9041-08-1 resistance.

Q: How quickly does heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates break up a clot?

A: Heparin is a strong, fast-acting anticoagulant (blood thinner). Heparin sodium salt CAS 9041-08-1 is given through a needle inserted in a vein (IV), but can also be given by injection under the skin. IV heparin works within minutes, and is usually given in the hospital.

Q: Does heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates cause hair loss?

A: Some anticoagulants, such as warfarin (Jantoven) and heparin, may cause hair loss by affecting the anagen phase of the hair cycle. You may begin to notice hair loss within 2 to 4 months of starting these medications.

Q: What happens when you stop taking heparin sodium salt CAS 9041-08-1 active pharmaceutical ingredients and intermediates?

A: Stopping heparin sodium salt CAS 9041-08-1 in patients not receiving aspirin or warfarin appears to expose them to an increased risk for TIA, stroke, or clinical deterioration.

Hot Tags: heparin sodium salt cas 9041-08-1 active pharmaceutical ingredients and intermediates, China heparin sodium salt cas 9041-08-1 active pharmaceutical ingredients and intermediates manufacturers, suppliers, CAS 9041 08 1, , , , CAS 19524 06 2